856 related articles for article (PubMed ID: 30769127)
1. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
Mirza R; Sharma B
Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of pioglitazone, a selective peroxisome proliferator-activated receptor-γ agonist in prenatal valproic acid-induced behavioral and biochemical autistic like features in Wistar rats.
Mirza R; Sharma B
Int J Dev Neurosci; 2019 Aug; 76():6-16. PubMed ID: 31128204
[TBL] [Abstract][Full Text] [Related]
3. Selective modulator of peroxisome proliferator-activated receptor-α protects propionic acid induced autism-like phenotypes in rats.
Mirza R; Sharma B
Life Sci; 2018 Dec; 214():106-117. PubMed ID: 30366038
[TBL] [Abstract][Full Text] [Related]
4. The neuroprotective effect of Diosgenin in the rat Valproic acid model of autism.
Reza Naghdi M; Ahadi R; Motamed Nezhad A; Sadat Ahmadi Tabatabaei F; Soleimani M; Hajisoltani R
Brain Res; 2024 Sep; 1838():148963. PubMed ID: 38705555
[TBL] [Abstract][Full Text] [Related]
5. A selective peroxisome proliferator-activated receptor-γ agonist benefited propionic acid induced autism-like behavioral phenotypes in rats by attenuation of neuroinflammation and oxidative stress.
Mirza R; Sharma B
Chem Biol Interact; 2019 Sep; 311():108758. PubMed ID: 31348919
[TBL] [Abstract][Full Text] [Related]
6. Benefits of agomelatine in behavioral, neurochemical and blood brain barrier alterations in prenatal valproic acid induced autism spectrum disorder.
Kumar H; Sharma BM; Sharma B
Neurochem Int; 2015 Dec; 91():34-45. PubMed ID: 26498253
[TBL] [Abstract][Full Text] [Related]
7. Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder.
Luhach K; Kulkarni GT; Singh VP; Sharma B
J Pharm Pharmacol; 2021 Oct; 73(11):1460-1469. PubMed ID: 34459916
[TBL] [Abstract][Full Text] [Related]
8. Memantine ameliorates autistic behavior, biochemistry & blood brain barrier impairments in rats.
Kumar H; Sharma B
Brain Res Bull; 2016 Jun; 124():27-39. PubMed ID: 27034117
[TBL] [Abstract][Full Text] [Related]
9. The histamine H3R antagonist DL77 attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism.
Eissa N; Jayaprakash P; Azimullah S; Ojha SK; Al-Houqani M; Jalal FY; Łażewska D; Kieć-Kononowicz K; Sadek B
Sci Rep; 2018 Aug; 8(1):13077. PubMed ID: 30166610
[TBL] [Abstract][Full Text] [Related]
10. Ameliorating effect of pioglitazone on prenatal valproic acid-induced behavioral and neurobiological abnormalities in autism spectrum disorder in rats.
Sandhu A; Rawat K; Gautam V; Bhatia A; Grover S; Saini L; Saha L
Pharmacol Biochem Behav; 2024 Apr; 237():173721. PubMed ID: 38307465
[TBL] [Abstract][Full Text] [Related]
11. Assessment of behavioral, morphological and electrophysiological changes in prenatal and postnatal valproate induced rat models of autism spectrum disorder.
Fereshetyan K; Chavushyan V; Danielyan M; Yenkoyan K
Sci Rep; 2021 Dec; 11(1):23471. PubMed ID: 34873263
[TBL] [Abstract][Full Text] [Related]
12. Minocycline ameliorates prenatal valproic acid induced autistic behaviour, biochemistry and blood brain barrier impairments in rats.
Kumar H; Sharma B
Brain Res; 2016 Jan; 1630():83-97. PubMed ID: 26551768
[TBL] [Abstract][Full Text] [Related]
13. Validation of prenatal versus postnatal valproic acid rat models of autism: A behavioral and neurobiological study.
Elnahas EM; Abuelezz SA; Mohamad MI; Nabil MM; Abdelraouf SM; Bahaa N; Hassan GA; Ibrahim EA; Ahmed AI; Aboul-Fotouh S
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110185. PubMed ID: 33238165
[TBL] [Abstract][Full Text] [Related]
14. Targeting PPARα in the rat valproic acid model of autism: focus on social motivational impairment and sex-related differences.
Scheggi S; Guzzi F; Braccagni G; De Montis MG; Parenti M; Gambarana C
Mol Autism; 2020 Jul; 11(1):62. PubMed ID: 32718349
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase inhibitor, ibudilast alleviates core behavioral and biochemical deficits in the prenatal valproic acid exposure model of autism spectrum disorder.
Sandhu A; Rawat K; Gautam V; Sharma A; Kumar A; Saha L
Brain Res; 2023 Sep; 1815():148443. PubMed ID: 37290608
[TBL] [Abstract][Full Text] [Related]
16. Prenatal Exposure to Valproic Acid Affects Microglia and Synaptic Ultrastructure in a Brain-Region-Specific Manner in Young-Adult Male Rats: Relevance to Autism Spectrum Disorders.
Gąssowska-Dobrowolska M; Cieślik M; Czapski GA; Jęśko H; Frontczak-Baniewicz M; Gewartowska M; Dominiak A; Polowy R; Filipkowski RK; Babiec L; Adamczyk A
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443651
[TBL] [Abstract][Full Text] [Related]
17. Vitamin A ameliorates valproic acid-induced autism-like symptoms in developing zebrafish larvae by attenuating oxidative stress and apoptosis.
Wang J; Zou L; Jiang P; Yao M; Xu Q; Hong Q; Zhu J; Chi X
Neurotoxicology; 2024 Mar; 101():93-101. PubMed ID: 38191030
[TBL] [Abstract][Full Text] [Related]
18. The effect of ketogenic diet in an animal model of autism induced by prenatal exposure to valproic acid.
Castro K; Baronio D; Perry IS; Riesgo RDS; Gottfried C
Nutr Neurosci; 2017 Jul; 20(6):343-350. PubMed ID: 26856821
[TBL] [Abstract][Full Text] [Related]
19. Vitamin A supplementation ameliorates prenatal valproic acid-induced autism-like behaviors in rats.
Liu Z; Wang J; Xu Q; Wu Z; You L; Hong Q; Zhu J; Chi X
Neurotoxicology; 2022 Jul; 91():155-165. PubMed ID: 35594946
[TBL] [Abstract][Full Text] [Related]
20. Vinpocetine amended prenatal valproic acid induced features of ASD possibly by altering markers of neuronal function, inflammation, and oxidative stress.
Luhach K; Kulkarni GT; Singh VP; Sharma B
Autism Res; 2021 Nov; 14(11):2270-2286. PubMed ID: 34415116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
